Reply To: Traders Market Weekly: Brand New Year, what is Ahead?

#69391
Truman
Participant

AstraZeneca (AZN 66.37, +0.08, +0.1%): Gracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseases for $10.00/ADS

RayzeBio (RYZB 60.25, +29.68, +97.1%): to be acquired by Bristol-Myers (BMY) for $62.50/share

HollySys (HOLI 27.05, +1.53, +6.0%): Buyer consortium led by Dazheng Group announces enhanced all-cash proposal of $29.00/share to acquire HOLI